Literature DB >> 33580232

Production and cryopreservation of definitive endoderm from human pluripotent stem cells under defined and scalable culture conditions.

Anais Sahabian1,2,3, Julia Dahlmann1,2,3, Ulrich Martin4,5,6, Ruth Olmer7,8,9.   

Abstract

The endodermal germ layer gives rise to respiratory epithelium, hepatocytes, pancreatic cells and intestinal lineages, among other cell types. These lineages can be differentiated from human pluripotent stem cells (hPSCs) via a common definitive endoderm (DE) intermediate that is characterized by the co-expression of the cell surface markers CXCR4, c-KIT and EPCAM and the transcription factors SOX17 and FOXA2. Here we provide a detailed protocol for mass production of DE from hPSCs in scalable and easy-to-handle suspension culture using a rotating Erlenmeyer flask or a sophisticated, fully controllable, 150-ml stirred tank bioreactor. This protocol uses two different media formulations that are chemically defined and xeno free and therefore good manufacturing practice ready. Our protocol allows for efficient hPSC-derived DE specification in multicellular aggregates within 3 days and generates up to 1 × 108 DE cells with >92% purity in one differentiation batch when using the bioreactor. The hPSC-derived DE cells that are generated can be cryopreserved for later downstream differentiation into various endodermal lineages. This protocol should facilitate the flexible production of mature DE derivatives for physiologically relevant disease models, high-throughput drug screening, toxicology testing and cellular therapies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33580232     DOI: 10.1038/s41596-020-00470-5

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  51 in total

1.  Modeling human lung development and disease using pluripotent stem cells.

Authors:  Hans-Willem Snoeck
Journal:  Development       Date:  2015-01-01       Impact factor: 6.868

Review 2.  Stem cells as a novel tool for drug screening and treatment of degenerative diseases.

Authors:  Ewa K Zuba-Surma; Wojciech Wojakowski; Zbigniew Madeja; Mariusz Z Ratajczak
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen.

Authors:  Arnaud Carpentier; Ila Nimgaonkar; Virginia Chu; Yuchen Xia; Zongyi Hu; T Jake Liang
Journal:  Stem Cell Res       Date:  2016-03-29       Impact factor: 2.020

Review 4.  Drug screening for human genetic diseases using iPSC models.

Authors:  Matthew S Elitt; Lilianne Barbar; Paul J Tesar
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 5.  Human Pluripotent Stem Cell-Derived Endoderm for Modeling Development and Clinical Applications.

Authors:  Loukia Yiangou; Alexander D B Ross; Kim Jee Goh; Ludovic Vallier
Journal:  Cell Stem Cell       Date:  2018-04-05       Impact factor: 24.633

6.  Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.

Authors:  Meike Hohwieler; Anett Illing; Patrick C Hermann; Tobias Mayer; Marianne Stockmann; Lukas Perkhofer; Tim Eiseler; Justin S Antony; Martin Müller; Susanne Renz; Chao-Chung Kuo; Qiong Lin; Matthias Sendler; Markus Breunig; Susanne M Kleiderman; André Lechel; Martin Zenker; Michael Leichsenring; Jonas Rosendahl; Martin Zenke; Bruno Sainz; Julia Mayerle; Ivan G Costa; Thomas Seufferlein; Michael Kormann; Martin Wagner; Stefan Liebau; Alexander Kleger
Journal:  Gut       Date:  2016-09-15       Impact factor: 23.059

7.  Induction of functional islet-like cells from human iPS cells by suspension culture.

Authors:  Shigeharu G Yabe; Satsuki Fukuda; Junko Nishida; Fujie Takeda; Kiyoko Nashiro; Hitoshi Okochi
Journal:  Regen Ther       Date:  2019-01-02       Impact factor: 3.419

8.  Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.

Authors:  Aditya Mithal; Amalia Capilla; Dar Heinze; Andrew Berical; Carlos Villacorta-Martin; Marall Vedaie; Anjali Jacob; Kristine Abo; Aleksander Szymaniak; Megan Peasley; Alexander Stuffer; John Mahoney; Darrell N Kotton; Finn Hawkins; Gustavo Mostoslavsky
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

Review 9.  Human pluripotent stem cells for modelling human liver diseases and cell therapy.

Authors:  Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne Weber; Anne Dubart-Kupperschmitt
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

10.  Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.

Authors:  Oksana Sirenko; Michael K Hancock; Jayne Hesley; Dihui Hong; Avrum Cohen; Jason Gentry; Coby B Carlson; David A Mann
Journal:  Assay Drug Dev Technol       Date:  2016-08-05       Impact factor: 1.738

View more
  5 in total

Review 1.  Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors.

Authors:  Mania Ackermann; Anna Rafiei Hashtchin; Robert Zweigerdt; Nico Lachmann; Felix Manstein; Marco Carvalho Oliveira; Henning Kempf
Journal:  Nat Protoc       Date:  2022-01-17       Impact factor: 17.021

2.  Process control and in silico modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors.

Authors:  Felix Manstein; Kevin Ullmann; Wiebke Triebert; Robert Zweigerdt
Journal:  STAR Protoc       Date:  2021-12-09

3.  Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy.

Authors:  Tingcai Pan; Ning Wang; Jiaye Zhang; Fan Yang; Yan Chen; Yuanqi Zhuang; Yingying Xu; Ji Fang; Kai You; Xianhua Lin; Yang Li; Shao Li; Kangyan Liang; Yin-Xiong Li; Yi Gao
Journal:  Stem Cell Res Ther       Date:  2022-04-11       Impact factor: 6.832

Review 4.  Reconstructing the pulmonary niche with stem cells: a lung story.

Authors:  Barbie Varghese; Zihan Ling; Xi Ren
Journal:  Stem Cell Res Ther       Date:  2022-04-11       Impact factor: 6.832

5.  Process parameter development for the scaled generation of stem cell-derived pancreatic endocrine cells.

Authors:  Diepiriye G Iworima; Sebastian Rieck; Timothy J Kieffer
Journal:  Stem Cells Transl Med       Date:  2021-08-13       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.